Quest Diagnostics Net Income 2010-2024 | DGX

Quest Diagnostics annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Quest Diagnostics net income for the quarter ending September 30, 2024 was $0.225B, a 0.9% increase year-over-year.
  • Quest Diagnostics net income for the twelve months ending September 30, 2024 was $838M, a 10.55% increase year-over-year.
  • Quest Diagnostics annual net income for 2023 was $0.85B, a 9.77% decline from 2022.
  • Quest Diagnostics annual net income for 2022 was $0.942B, a 52.62% decline from 2021.
  • Quest Diagnostics annual net income for 2021 was $1.988B, a 39.51% increase from 2020.
Quest Diagnostics Annual Net Income
(Millions of US $)
2023 $850
2022 $942
2021 $1,988
2020 $1,425
2019 $858
2018 $736
2017 $772
2016 $642
2015 $706
2014 $556
2013 $849
2012 $556
2011 $471
2010 $721
2009 $729
Quest Diagnostics Quarterly Net Income
(Millions of US $)
2024-09-30 $225
2024-06-30 $229
2024-03-31 $194
2023-12-31 $190
2023-09-30 $223
2023-06-30 $235
2023-03-31 $202
2022-12-31 $98
2022-09-30 $256
2022-06-30 $233
2022-03-31 $355
2021-12-31 $383
2021-09-30 $505
2021-06-30 $631
2021-03-31 $469
2020-12-31 $573
2020-09-30 $568
2020-06-30 $185
2020-03-31 $99
2019-12-31 $253
2019-09-30 $215
2019-06-30 $226
2019-03-31 $164
2018-12-31 $127
2018-09-30 $213
2018-06-30 $219
2018-03-31 $177
2017-12-31 $254
2017-09-30 $161
2017-06-30 $193
2017-03-31 $164
2016-12-31 $152
2016-09-30 $192
2016-06-30 $195
2016-03-31 $103
2015-12-31 $185
2015-09-30 $342
2015-06-30 $118
2015-03-31 $61
2014-12-31 $190
2014-09-30 $129
2014-06-30 $133
2014-03-31 $104
2013-12-31 $143
2013-09-30 $405
2013-06-30 $165
2013-03-31 $136
2012-12-31 $56
2012-09-30 $163
2012-06-30 $178
2012-03-31 $159
2011-12-31 $190
2011-09-30 $172
2011-06-30 $163
2011-03-31 $-54
2010-12-31 $166
2010-09-30 $198
2010-06-30 $195
2010-03-31 $162
2009-12-31 $182
2009-09-30 $192
2009-06-30 $188
2009-03-31 $167
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.988B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00